Show Summary Details
Page of

The Multimodal Treatment of Children with ADHD (MTA) Follow-up Study: Outcomes and Their Predictors 

The Multimodal Treatment of Children with ADHD (MTA) Follow-up Study: Outcomes and Their Predictors
Chapter:
The Multimodal Treatment of Children with ADHD (MTA) Follow-up Study: Outcomes and Their Predictors
Author(s):

Arunima Roy

and Lily Hechtman

DOI:
10.1093/med/9780190213589.003.0008
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 May 2022

The Multimodal Treatment of Children with ADHD (MTA) study was a 14-month randomized clinical trial with naturalistic follow-ups of participants (579 children with ADHD and 259 matched community controls) after treatment for a total of 16 years. Results from this study showed a superiority of multimodal treatment regimens for ADHD compared with the commonly available community care. Nevertheless, symptom and functioning improvements brought about by multimodal therapy lapsed after cessation of therapy. In short, the MTA study showed that ADHD is a chronic condition, requiring continuous, long-term, and well-monitored treatments. Furthermore, results showed that ADHD symptoms persist into adulthood in about half the sample, and that persistence is associated with poorer outcomes than remission or no childhood ADHD.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.